Theravance Biopharma (TBPH) EBT Margin Growth (3y) (2016 - 2026)
Theravance Biopharma (TBPH) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | 17,927.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,927.00 |
| Dec 31, 2025 | 21,111.00 |
| Sep 30, 2025 | 11,424.00 |
| Jun 30, 2025 | 48,578.00 |
| Mar 31, 2025 | 20,924.00 |
| Dec 31, 2024 | 34,017.00 |
| Sep 30, 2024 | 36,421.00 |
| Jun 30, 2024 | 30,073.00 |
| Mar 31, 2024 | 48,556.00 |
| Dec 31, 2023 | 42,013.00 |
| Sep 30, 2023 | 35,454.00 |
| Jun 30, 2023 | 31,558.00 |
| Mar 31, 2023 | 20,158.00 |
| Dec 31, 2022 | -7,002.00 |
| Sep 30, 2022 | 38,618.00 |
| Jun 30, 2022 | -13,291.00 |
| Mar 31, 2022 | 105,707.00 |
| Dec 31, 2021 | -4,824.00 |
| Sep 30, 2021 | 4,427.00 |
| Jun 30, 2021 | -20,471.00 |